Data show that treatment with a single-pill combination of telmisartan, an angiotensin receptor blocker, (ARB) and amlodipine, a calcium channel blocker (CCB) results in significant reductions in blood pressure (BP) in patients with severe hypertension…
More: continued here
A detailed study conducted by a team from the University of Athens on the Aegean island of Ikaria has demonstrated that moderate consumption of coffee by hypertensive elderly individuals can lead to improvements in aortic distensibility…
More: continued here
A study of the body system that deals with Americans’ love affair with salt may yield more insight into why so many end up hypertensive and how to better treat them. A team of scientists from the Medical
More: continued here
Research prize for Bochum’s medics They also pointed out that the disease can be diagnosed and counteracted by means of a simple comparison between arm and ankle blood pressure carried out by a GP. Their highly regarded work has now been conferred the Best PAD Research Award 2010 by the Peripheral Arterial Disease Coalition…
More: continued here
The US Food and Drug Administration (FDA) approved Tekamlo® (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna® (aliskiren) with the widely used calcium channel blocker, amlodipine1…
More: continued here
Novartis’ single pill combination of aliskiren and amlopidine – Tekamlo – has been approved by the Food and Drug Administration (FDA) for the treatment of hypertension. Data revealed that Tekamlo significantly reduced blood pressure compared to amlodipine or aliskiren (Tekturna) alone. The medication has been approved in tablet form…
More: continued here
A British study of 270 salads and pasta bowls purchased from retail outlets, supermarkets, cafes and fast food restaurants revealed that a surprising number of them contained more than half of our daily recommended salt intake…
More: continued here
Actelion Pharmaceuticals US, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved the brand name VELETRI® for the company’s epoprostenol for injection therapy…
More: continued here
A small amount of aspirin a day could help certain groups of pregnant women keep a potentially serious and sometimes fatal condition at bay. The National Institute for Health and Clinical Excellence (NICE) says this is just one of a number of ways to help prevent and treat hypertension (high blood pressure) before, during and after pregnancy…
More: continued here
University of Texas Medical
More: continued here
